Working… Menu

Glucose in Dialysis Water in Non-diabetics

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00439023
Recruitment Status : Completed
First Posted : February 22, 2007
Last Update Posted : September 15, 2015
Information provided by:
Regional Hospital Holstebro

Brief Summary:

The purposes are

  1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and
  2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

Condition or disease Intervention/treatment Phase
Renal Failure, Chronic Procedure: dialysis with glucose in dialysis water Phase 4

Detailed Description:
Measurement of hormones and blood pressure during dialysis treatment.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 18 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Glucose in Dialysis Water on Blood Pressure and Vasoactive Hormones in Dialysis Patients
Study Start Date : May 2006
Actual Study Completion Date : May 2007

Resource links provided by the National Library of Medicine

Drug Information available for: Dextrose

Primary Outcome Measures :
  1. Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones [ Time Frame: one week ]

Secondary Outcome Measures :
  1. Relationship between changes in blood pressure and changes in hormones during treatment [ Time Frame: one week ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  1. Age > 18 years,
  2. Both men and women,
  3. Dialysis treatment for at least three months

Exclusion Criteria:

  1. Heart failure,
  2. Chronic liver disease,
  3. Diabetes mellitus,
  4. Malignant disease,
  5. Nephrotic syndrome,
  6. Lack of compliance, 7 Unwillingness to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00439023

Layout table for location information
Holstebro Hospital
Holstebro, Denmark, 7500
Sponsors and Collaborators
Regional Hospital Holstebro
Layout table for investigator information
Study Chair: Erling B Pedersen, Professor Regional Hospital Holstebro
Layout table for additonal information Identifier: NCT00439023    
Other Study ID Numbers: MED.RES.2007.01.EBP
First Posted: February 22, 2007    Key Record Dates
Last Update Posted: September 15, 2015
Last Verified: September 2007
Keywords provided by Regional Hospital Holstebro:
Chronic renal failure, dialysis, hemodialysis,
Additional relevant MeSH terms:
Layout table for MeSH terms
Renal Insufficiency
Kidney Failure, Chronic
Kidney Diseases
Urologic Diseases
Renal Insufficiency, Chronic